Related Experiment Video
Updated: Oct 13, 2025

11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
39.1K
Methotrexate in erythema nodosum leprosum: Pitfalls to avoid
Hitaishi Mehta1, Tarun Narang1, Sunil Dogra1
1Department of Dermatology, Venereology and Leprology; 29751Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Tropical Doctor
|November 17, 2021
Summary
This study highlights two cases of erythema nodosum leprosum (ENL) with atypical features that responded well to low-dose methotrexate. It supports the rational use of methotrexate for managing complex ENL cases.
Area of Science:
- Dermatology
- Rheumatology
- Infectious Diseases
Background:
- Erythema nodosum leprosum (ENL) is a complex inflammatory complication of leprosy.
- Atypical presentations of ENL pose diagnostic and therapeutic challenges.
- Methotrexate is a potential treatment option, but its use in ENL requires careful consideration.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
286
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
286
Therapeutic Drug Monitoring: Affecting Factors
16
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
16
Nephrotic Syndrome II : Assessment and Medical Management
35
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
35

